Teza Capital Management’s AbbVie ABBV Stock Holding History

Teza Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$368K	Sell	1,407 -176	-11%	-$45.1K	0.33%	123
2026 Q2	$398K	Buy	1,583 +6	+0.4%	+$1.29K	0.77%	55
2026 Q1	$343K	Sell	1,577 -1,141	-42%	-$253K	1.26%	26
2025 Q4	$621K	Buy	2,718 +1,251	+85%	+$285K	2%	10
2025 Q3	$340K	Sell	1,467 -3,062	-68%	-$624K	1.84%	22
2025 Q2	$841K	Buy	4,529 +177	+4%	+$32.9K	0.63%	27
2025 Q1	$912K	Buy	4,352 +2,945	+209%	+$573K	0.42%	67
2024 Q4	$250K	Sell	1,407 -3,629	-72%	-$667K	0.04%	393
2024 Q3	$995K	Buy	5,036 +3,629	+258%	+$677K	0.11%	259
2024 Q2	$241K	Buy	+1,407	New	+$233K	0.03%	499
2024 Q1	–	Sell	-18,884	Closed	-$2.93M	–	548
2023 Q4	$2.93M	Buy	18,884 +14,032	+289%	+$2.05M	0.49%	42
2023 Q3	$723K	Sell	4,852 -48,455	-91%	-$7.11M	0.12%	244
2023 Q2	$7.18M	Buy	+53,307	New	+$7.82M	1.17%	6
2023 Q1	–	Sell	-3,241	Closed	-$524K	–	488
2022 Q4	$524K	Buy	+3,241	New	+$497K	0.1%	314
2022 Q1	–	Sell	-20,012	Closed	-$2.71M	–	398
2021 Q4	$2.71M	Buy	20,012 +16,154	+419%	+$1.91M	0.73%	28
2021 Q3	$416K	Sell	3,858 -53,076	-93%	-$6.06M	0.2%	156
2021 Q2	$6.41M	Buy	+56,934	New	+$6.41M	1.04%	5
2021 Q1	–	Sell	-6,728	Closed	-$721K	–	457
2020 Q4	$721K	Sell	6,728 -19,123	-74%	-$1.84M	0.41%	73
2020 Q3	$2.26M	Buy	+25,851	New	+$2.43M	1.33%	4
2018 Q3	–	Sell	-10,872	Closed	-$1.01M	–	355
2018 Q2	$1.01M	Buy	10,872 +229	+2%	+$22.4K	0.15%	236
2018 Q1	$1.01M	Buy	10,643 +2,479	+30%	+$272K	0.24%	164
2017 Q4	$790K	Buy	+8,164	New	+$769K	0.48%	88
2017 Q2	–	Sell	-14,201	Closed	-$925K	–	2
2017 Q1	$925K	Buy	+14,201	New	+$893K	0.27%	117

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Teza Capital Management's ABBV Position: Q3 2026 in Review

Teza Capital Management reduced its AbbVie (ABBV) stake by 11% in Q3 2026, selling an estimated $45.1K and leaving 1,407 shares worth $368K. The position accounts for 0.33% of the portfolio, ranked #123.

Teza Capital Management first reported a position in ABBV in Q1 2017 and has held it in 23 quarters since. The position peaked at $7.18M in Q2 2023. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Teza Capital Management held 1,407 shares of AbbVie worth $368K as of Q3 2026.
Teza Capital Management sold 176 AbbVie shares in Q3 2026, an estimated $45.1K.
AbbVie made up 0.33% of Teza Capital Management's portfolio in Q3 2026, its #123 holding.
Teza Capital Management first reported a position in AbbVie in Q1 2017 and has held it in 23 quarters since.
Teza Capital Management's AbbVie position peaked at $7.18M in Q2 2023.
3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Teza Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.